Skip to main content
Top
Published in: Virology Journal 1/2010

Open Access 01-12-2010 | Research

Species-independent bioassay for sensitive quantification of antiviral type I interferons

Authors: Thomas Kuri, Matthias Habjan, Nicola Penski, Friedemann Weber

Published in: Virology Journal | Issue 1/2010

Login to get access

Abstract

Background

Studies of the host response to infection often require quantitative measurement of the antiviral type I interferons (IFN-α/β) in biological samples. The amount of IFN is either determined via its ability to suppress a sensitive indicator virus, by an IFN-responding reporter cell line, or by ELISA. These assays however are either time-consuming and lack convenient readouts, or they are rather insensitive and restricted to IFN from a particular host species.

Results

An IFN-sensitive, Renilla luciferase-expressing Rift Valley fever virus (RVFV-Ren) was generated using reverse genetics. Human, murine and avian cells were tested for their susceptibility to RVFV-Ren after treatment with species-specific IFNs. RVFV-Ren was able to infect cells of all three species, and IFN-mediated inhibition of viral reporter activity occurred in a dose-dependent manner. The sensitivity limit was found to be 1 U/ml IFN, and comparison with a standard curve allowed to determine the activity of an unknown sample.

Conclusions

RVFV-Ren replicates in cells of several species and is highly sensitive to pre-treatment with IFN. These properties allowed the development of a rapid, sensitive, and species-independent antiviral assay with a convenient luciferase-based readout.
Appendix
Available only for authorised users
Literature
1.
go back to reference Haller O, Kochs G, Weber F: The interferon response circuit: induction and suppression by pathogenic viruses. Virology 2006, 344: 119-130. 10.1016/j.virol.2005.09.024PubMedCrossRef Haller O, Kochs G, Weber F: The interferon response circuit: induction and suppression by pathogenic viruses. Virology 2006, 344: 119-130. 10.1016/j.virol.2005.09.024PubMedCrossRef
2.
go back to reference Randall RE, Goodbourn S: Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol 2008, 89: 1-47. 10.1099/vir.0.83391-0PubMedCrossRef Randall RE, Goodbourn S: Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol 2008, 89: 1-47. 10.1099/vir.0.83391-0PubMedCrossRef
3.
go back to reference Meager A: Biological assays for interferons. J Immunol Methods 2002, 261: 21-36. 10.1016/S0022-1759(01)00570-1PubMedCrossRef Meager A: Biological assays for interferons. J Immunol Methods 2002, 261: 21-36. 10.1016/S0022-1759(01)00570-1PubMedCrossRef
4.
go back to reference Uno K, Sato T, Takada Y, Fujioka K, Suginoshita Y, Kakimi K, Moriyasu F, Kishida T: A bioassay for serum interferon based on induction of 2'5'-oligoadenylate synthetase activity. J Interferon Cytokine Res 1998, 18: 1011-1018. 10.1089/jir.1998.18.1011PubMedCrossRef Uno K, Sato T, Takada Y, Fujioka K, Suginoshita Y, Kakimi K, Moriyasu F, Kishida T: A bioassay for serum interferon based on induction of 2'5'-oligoadenylate synthetase activity. J Interferon Cytokine Res 1998, 18: 1011-1018. 10.1089/jir.1998.18.1011PubMedCrossRef
5.
go back to reference Canosi U, Mascia M, Gazza L, Serlupi-Crescenzi O, Donini S, Antonetti F, Galli G: A highly precise reporter gene bioassay for type I interferon. J Immunol Methods 1996, 199: 69-76. 10.1016/S0022-1759(96)00168-8PubMedCrossRef Canosi U, Mascia M, Gazza L, Serlupi-Crescenzi O, Donini S, Antonetti F, Galli G: A highly precise reporter gene bioassay for type I interferon. J Immunol Methods 1996, 199: 69-76. 10.1016/S0022-1759(96)00168-8PubMedCrossRef
6.
go back to reference Francois C, Bernard I, Castelain S, Charleston B, Fray MD, Capiod JC, Duverlie G: Quantification of different human alpha interferon subtypes and pegylated interferon activities by measuring MxA promoter activation. Antimicrob Agents Chemother 2005, 49: 3770-3775. 10.1128/AAC.49.9.3770-3775.2005PubMedPubMedCentralCrossRef Francois C, Bernard I, Castelain S, Charleston B, Fray MD, Capiod JC, Duverlie G: Quantification of different human alpha interferon subtypes and pegylated interferon activities by measuring MxA promoter activation. Antimicrob Agents Chemother 2005, 49: 3770-3775. 10.1128/AAC.49.9.3770-3775.2005PubMedPubMedCentralCrossRef
7.
go back to reference Lleonart R, Naf D, Browning H, Weissmann C: A novel, quantitative bioassay for type I interferon using a recombinant indicator cell line. Biotechnology (N Y) 1990, 8: 1263-1267. 10.1038/nbt1290-1263CrossRef Lleonart R, Naf D, Browning H, Weissmann C: A novel, quantitative bioassay for type I interferon using a recombinant indicator cell line. Biotechnology (N Y) 1990, 8: 1263-1267. 10.1038/nbt1290-1263CrossRef
8.
go back to reference Schwarz H, Harlin O, Ohnemus A, Kaspers B, Staeheli P: Synthesis of IFN-beta by virus-infected chicken embryo cells demonstrated with specific antisera and a new bioassay. J Interferon Cytokine Res 2004, 24: 179-184. 10.1089/107999004322917025PubMedCrossRef Schwarz H, Harlin O, Ohnemus A, Kaspers B, Staeheli P: Synthesis of IFN-beta by virus-infected chicken embryo cells demonstrated with specific antisera and a new bioassay. J Interferon Cytokine Res 2004, 24: 179-184. 10.1089/107999004322917025PubMedCrossRef
9.
go back to reference Holzinger D, Jorns C, Stertz S, Boisson-Dupuis S, Thimme R, Weidmann M, Casanova JL, Haller O, Kochs G: Induction of MxA gene expression by influenza A virus requires type I or type III interferon signaling. J Virol 2007, 81: 7776-7785. 10.1128/JVI.00546-06PubMedPubMedCentralCrossRef Holzinger D, Jorns C, Stertz S, Boisson-Dupuis S, Thimme R, Weidmann M, Casanova JL, Haller O, Kochs G: Induction of MxA gene expression by influenza A virus requires type I or type III interferon signaling. J Virol 2007, 81: 7776-7785. 10.1128/JVI.00546-06PubMedPubMedCentralCrossRef
10.
go back to reference Ferreira PC, Peixoto ML, Silva MA, Golgher RR: Assay of human interferon in Vero cells by several methods. J Clin Microbiol 1979, 9: 471-475.PubMedPubMedCentral Ferreira PC, Peixoto ML, Silva MA, Golgher RR: Assay of human interferon in Vero cells by several methods. J Clin Microbiol 1979, 9: 471-475.PubMedPubMedCentral
11.
go back to reference Perler L, Pfister H, Schweizer M, Peterhans E, Jungi TW: A bioassay for interferon type I based on inhibition of Sendai virus growth. J Immunol Methods 1999, 222: 189-196. 10.1016/S0022-1759(98)00198-7PubMedCrossRef Perler L, Pfister H, Schweizer M, Peterhans E, Jungi TW: A bioassay for interferon type I based on inhibition of Sendai virus growth. J Immunol Methods 1999, 222: 189-196. 10.1016/S0022-1759(98)00198-7PubMedCrossRef
12.
go back to reference Martinez-Sobrido L, Giannakas P, Cubitt B, Garcia-Sastre A, de la Torre JC: Differential inhibition of type I interferon induction by arenavirus nucleoproteins. J Virol 2007, 81: 12696-12703. 10.1128/JVI.00882-07PubMedPubMedCentralCrossRef Martinez-Sobrido L, Giannakas P, Cubitt B, Garcia-Sastre A, de la Torre JC: Differential inhibition of type I interferon induction by arenavirus nucleoproteins. J Virol 2007, 81: 12696-12703. 10.1128/JVI.00882-07PubMedPubMedCentralCrossRef
13.
go back to reference Munoz-Jordan JL, Laurent-Rolle M, Ashour J, Martinez-Sobrido L, Ashok M, Lipkin WI, Garcia-Sastre A: Inhibition of alpha/beta interferon signaling by the NS4B protein of flaviviruses. J Virol 2005, 79: 8004-8013. 10.1128/JVI.79.13.8004-8013.2005PubMedPubMedCentralCrossRef Munoz-Jordan JL, Laurent-Rolle M, Ashour J, Martinez-Sobrido L, Ashok M, Lipkin WI, Garcia-Sastre A: Inhibition of alpha/beta interferon signaling by the NS4B protein of flaviviruses. J Virol 2005, 79: 8004-8013. 10.1128/JVI.79.13.8004-8013.2005PubMedPubMedCentralCrossRef
14.
go back to reference Newby CM, Sabin L, Pekosz A: The RNA binding domain of influenza A virus NS1 protein affects secretion of tumor necrosis factor alpha, interleukin-6, and interferon in primary murine tracheal epithelial cells. J Virol 2007, 81: 9469-9480. 10.1128/JVI.00989-07PubMedPubMedCentralCrossRef Newby CM, Sabin L, Pekosz A: The RNA binding domain of influenza A virus NS1 protein affects secretion of tumor necrosis factor alpha, interleukin-6, and interferon in primary murine tracheal epithelial cells. J Virol 2007, 81: 9469-9480. 10.1128/JVI.00989-07PubMedPubMedCentralCrossRef
15.
go back to reference Billecocq A, Spiegel M, Vialat P, Kohl A, Weber F, Bouloy M, Haller O: NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription. J Virol 2004, 78: 9798-9806. 10.1128/JVI.78.18.9798-9806.2004PubMedPubMedCentralCrossRef Billecocq A, Spiegel M, Vialat P, Kohl A, Weber F, Bouloy M, Haller O: NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription. J Virol 2004, 78: 9798-9806. 10.1128/JVI.78.18.9798-9806.2004PubMedPubMedCentralCrossRef
16.
go back to reference Bouloy M, Janzen C, Vialat P, Khun H, Pavlovic J, Huerre M, Haller O: Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs. J Virol 2001, 75: 1371-1377. 10.1128/JVI.75.3.1371-1377.2001PubMedPubMedCentralCrossRef Bouloy M, Janzen C, Vialat P, Khun H, Pavlovic J, Huerre M, Haller O: Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs. J Virol 2001, 75: 1371-1377. 10.1128/JVI.75.3.1371-1377.2001PubMedPubMedCentralCrossRef
17.
go back to reference Frese M, Kochs G, Feldmann H, Hertkorn C, Haller O: Inhibition of bunyaviruses, phleboviruses, and hantaviruses by human MxA protein. J Virol 1996, 70: 915-923.PubMedPubMedCentral Frese M, Kochs G, Feldmann H, Hertkorn C, Haller O: Inhibition of bunyaviruses, phleboviruses, and hantaviruses by human MxA protein. J Virol 1996, 70: 915-923.PubMedPubMedCentral
18.
go back to reference Habjan M, Penski N, Wagner V, Spiegel M, Overby AK, Kochs G, Huiskonen JT, Weber F: Efficient production of Rift Valley fever virus-like particles: The antiviral protein MxA can inhibit primary transcription of bunyaviruses. Virology 2009, 385: 400-408. 10.1016/j.virol.2008.12.011PubMedCrossRef Habjan M, Penski N, Wagner V, Spiegel M, Overby AK, Kochs G, Huiskonen JT, Weber F: Efficient production of Rift Valley fever virus-like particles: The antiviral protein MxA can inhibit primary transcription of bunyaviruses. Virology 2009, 385: 400-408. 10.1016/j.virol.2008.12.011PubMedCrossRef
19.
go back to reference Habjan M, Pichlmair A, Elliott RM, Overby AK, Glatter T, Gstaiger M, Superti-Furga G, Unger H, Weber F: NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase. J Virol 2009, 83: 4365-4375. 10.1128/JVI.02148-08PubMedPubMedCentralCrossRef Habjan M, Pichlmair A, Elliott RM, Overby AK, Glatter T, Gstaiger M, Superti-Furga G, Unger H, Weber F: NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase. J Virol 2009, 83: 4365-4375. 10.1128/JVI.02148-08PubMedPubMedCentralCrossRef
20.
go back to reference Ikegami T, Narayanan K, Won S, Kamitani W, Peters CJ, Makino S: Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation. PLoS Pathog 2009, 5: e1000287. 10.1371/journal.ppat.1000287PubMedPubMedCentralCrossRef Ikegami T, Narayanan K, Won S, Kamitani W, Peters CJ, Makino S: Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation. PLoS Pathog 2009, 5: e1000287. 10.1371/journal.ppat.1000287PubMedPubMedCentralCrossRef
21.
go back to reference Habjan M, Penski N, Spiegel M, Weber F: T7 RNA polymerase-dependent and -independent systems for cDNA-based rescue of Rift Valley fever virus. J Gen Virol 2008, 89: 2157-2166. 10.1099/vir.0.2008/002097-0PubMedCrossRef Habjan M, Penski N, Spiegel M, Weber F: T7 RNA polymerase-dependent and -independent systems for cDNA-based rescue of Rift Valley fever virus. J Gen Virol 2008, 89: 2157-2166. 10.1099/vir.0.2008/002097-0PubMedCrossRef
22.
go back to reference Blakqori G, Delhaye S, Habjan M, Blair CD, Sanchez-Vargas I, Olson KE, Attarzadeh-Yazdi G, Fragkoudis R, Kohl A, Kalinke U, et al.: La Crosse bunyavirus nonstructural protein NSs serves to suppress the type I interferon system of mammalian hosts. J Virol 2007, 81: 4991-4999. 10.1128/JVI.01933-06PubMedPubMedCentralCrossRef Blakqori G, Delhaye S, Habjan M, Blair CD, Sanchez-Vargas I, Olson KE, Attarzadeh-Yazdi G, Fragkoudis R, Kohl A, Kalinke U, et al.: La Crosse bunyavirus nonstructural protein NSs serves to suppress the type I interferon system of mammalian hosts. J Virol 2007, 81: 4991-4999. 10.1128/JVI.01933-06PubMedPubMedCentralCrossRef
23.
go back to reference Schultz U, Kock J, Schlicht HJ, Staeheli P: Recombinant duck interferon: a new reagent for studying the mode of interferon action against hepatitis B virus. Virology 1995, 212: 641-649. 10.1006/viro.1995.1522PubMedCrossRef Schultz U, Kock J, Schlicht HJ, Staeheli P: Recombinant duck interferon: a new reagent for studying the mode of interferon action against hepatitis B virus. Virology 1995, 212: 641-649. 10.1006/viro.1995.1522PubMedCrossRef
24.
go back to reference Schultz U, Rinderle C, Sekellick MJ, Marcus PI, Staeheli P: Recombinant chicken interferon from Escherichia coli and transfected COS cells is biologically active. Eur J Biochem 1995, 229: 73-76. 10.1111/j.1432-1033.1995.0073l.xPubMedCrossRef Schultz U, Rinderle C, Sekellick MJ, Marcus PI, Staeheli P: Recombinant chicken interferon from Escherichia coli and transfected COS cells is biologically active. Eur J Biochem 1995, 229: 73-76. 10.1111/j.1432-1033.1995.0073l.xPubMedCrossRef
25.
go back to reference Barrett AD, Hunt N, Dimmock NJ: A rapid method for the inactivation of virus infectivity prior to assay for interferons. J Virol Methods 1984, 8: 349-351. 10.1016/0166-0934(84)90072-7PubMedCrossRef Barrett AD, Hunt N, Dimmock NJ: A rapid method for the inactivation of virus infectivity prior to assay for interferons. J Virol Methods 1984, 8: 349-351. 10.1016/0166-0934(84)90072-7PubMedCrossRef
Metadata
Title
Species-independent bioassay for sensitive quantification of antiviral type I interferons
Authors
Thomas Kuri
Matthias Habjan
Nicola Penski
Friedemann Weber
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2010
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-7-50

Other articles of this Issue 1/2010

Virology Journal 1/2010 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.